Mastocytosis: molecular mechanisms and clinical disease heterogeneity.
about
CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markersEvolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.Mastocytosis in childhood.Autism: an emerging 'neuroimmune disorder' in search of therapy.Diagnosis and treatment of systemic mastocytosis: state of the art.Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia.On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts.Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM).Clonality and molecular pathogenesis of mastocytosis.Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.Origin of stem cells in the BM niche: new clues from mastocytosis.Mast cells as novel mediators of reproductive processesClinical correlates of blood serotonin levels in patients with mastocytosis.Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.Mastocytosis in children and adults: clinical disease heterogeneityOncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascadeDetection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis.Autism spectrum disorders and mastocytosis.A transgenic zebrafish model expressing KIT-D816V recapitulates features of aggressive systemic mastocytosis.
P2860
Q21203579-16931572-C243-4D2F-A2C2-15BB8CA91747Q30914592-9082CD5A-ADAB-454E-97F7-A9E6743B8609Q34969725-44ECBD29-3BFF-4387-AE78-8BBF07D62878Q34994653-2E9A75B1-F60A-4150-B2DF-0EB186F82D16Q35203889-F1026E6D-597A-47F9-A9D5-C620D434BB55Q35807869-8D408E1D-13E5-403D-BE93-4D36CAA460D5Q35854970-82155D09-8494-489A-BEDE-F09044CB9184Q35900583-B69B2A2B-EBAA-4F44-8AD9-740A0EBF8E8DQ36182758-48DE1D13-114F-4E25-816D-1400C0F5B121Q36403080-56A5100A-CF37-4E05-BAA1-0A483C92132AQ36572914-DD360557-7395-498D-8971-42E764F11213Q36610406-A7E98929-D319-481A-943C-4928EEB93BE3Q37226647-54DE224C-18C4-4204-BE8F-5339A60ACBF0Q38582624-FFFD7BB7-65E4-4282-BEE2-E923A20D2930Q41812863-A488AED0-6FF5-4803-8067-C475B17079A9Q42243338-874B9A35-74EF-4C7D-A196-8B52FA20AA6AQ42433996-E537D9C5-8DBA-4008-B3DD-448135E05614Q43413777-81CA83BA-1E35-470D-947C-0FCA922A5EEFQ48345348-7E036BD3-484A-45CD-BE61-73DA825CDB58Q50651368-684D949C-6132-4DCB-AFF7-49B7C885FB02
P2860
Mastocytosis: molecular mechanisms and clinical disease heterogeneity.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mastocytosis: molecular mechanisms and clinical disease heterogeneity.
@ast
Mastocytosis: molecular mechanisms and clinical disease heterogeneity.
@en
Mastocytosis: molecular mechanisms and clinical disease heterogeneity.
@nl
type
label
Mastocytosis: molecular mechanisms and clinical disease heterogeneity.
@ast
Mastocytosis: molecular mechanisms and clinical disease heterogeneity.
@en
Mastocytosis: molecular mechanisms and clinical disease heterogeneity.
@nl
prefLabel
Mastocytosis: molecular mechanisms and clinical disease heterogeneity.
@ast
Mastocytosis: molecular mechanisms and clinical disease heterogeneity.
@en
Mastocytosis: molecular mechanisms and clinical disease heterogeneity.
@nl
P1433
P1476
Mastocytosis: molecular mechanisms and clinical disease heterogeneity
@en
P2093
D D Metcalfe
P304
P356
10.1016/S0145-2126(01)00046-7
P50
P577
2001-07-01T00:00:00Z